The company has set up an mRNA vaccine production base of nearly 50,000 square meters in Zhangjiang High-tech Park in Pudong New Area and Dongfang Meigu Industrial Park in Fengxian District, Shanghai, taking the lead in the large-scale production process of mRNA vaccines, and using the stock solution production and preparation production technology with independent intellectual property rights, breaking through the bottleneck of mRNA vaccine industrialization. It has a production capacity of 400 million doses a year and is equipped with world-leading mRNA production equipment. Stemirna is currently one of the largest and world-class mRNA vaccine manufacturing facilities in Asia.